News
Pfizer said on Tuesday its cancer drug Padcev, in combination with Merck's Keytruda, significantly improved survival rates in ...
Pfizer (NYSE: PFE) is a case in point, with its forward dividend yield of 7%. Although the stock is a favorite for many ...
Padcev, an antibody-drug conjugate which Pfizer acquired via its $43 billion Seagen deal, could help people who don’t qualify ...
Pfizer Inc. (NYSE:PFE) discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the ...
12h
mlive on MSN‘Potential exposure’ at Portage Pfizer plant sends people to hospital, MIOSHA investigating
Several workers reported symptoms of being exposed to a substance and some were taken to the hospital. The state is ...
Investor sentiment has been adversely affected by worries regarding the company’s drug pipeline. Nonetheless, we believe PFE ...
Pfizer (PFE 0.06%) has been a terrible investment over the past three years. Revenue and earnings have generally moved in the wrong direction, as the company has been unable to fo ...
Pfizer said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting ...
Today’s Stock of the Day list features three high-potential picks: Shilpa Medicare, Pfizer, and Vishal Mega Mart. Shilpa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results